Litigation Law, Mediation Law and Arbitration Law

On February 16, 2012, the Ontario Court of Appeal released a decision that comes as good news to issuers. In the case of Sharma v. Timminco Limited,1 the Court provided clear guidance on the conduct of secondary market securities class actions pursuant to section 138.3 of Part XXIII. of the Ontario Securities Act (the "OSA").

Fairness opinions and their quality are not generally highly-charged, emotional subjects in Canada.

Out of the US Supreme Court comes a positive development for Canadian issuers of securities who have business operations in the United States: the US Supreme Court held, on June 24, 2010, that the principal statutory provisions used by security-holders to bring class actions in the US — s.10(b) of the Securities and Exchange Act of 1934 and SEC Rule 10b-5 (which is promulgated under s. 10(b)) — have no application to trades in securities that are not traded on a US exchange and that do not take

Companies victimized by cheque fraud from within their own ranks often turn to their banks for recovery.

In February 2002, the parties to several actions which arose out of the meteoric rise and fall of the fortunes of YBM Magnex International, Inc. ("YBM") announced a settlement agreement (subject to court approval) following a three-week settlement conference.

In October 2011, two Ontario Court of Appeal judges, Justice Michael Moldaver and Justice Andromache Karakatsanis, were appointed to the Supreme Court of Canada.

Following are our summaries of the civil decisions of the Court of Appeal for Ontario for the week of September 15, 2025.

When I was in my third year of law school, 1L and 2L students constantly asked me two things...

In Terry Longair Professional Corporation v. Akumin Inc., the Court upheld the certification of a class action against a public company and its officers for alleged misrepresentations...

On June 8, 2012, Genentech’s lawsuit seeking a declaration that US Patent No. 6,733,752 was invalid and not-infringed by Genentech’s trastuzumab product (HERCEPTIN).

On April 19, 2012, the Québec Court of Appeal (the Court) rendered the first decision on misleading advertising since the ruling of the Supreme Court of Canada (the SCC) in Richard v. Time Inc. In Perreault v. McNeil PDI Inc.,

This bulletin outlines numerous recent developments affecting the health sector covering the areas of constitutional law, procurement law and privacy law.